검색어 : 통합검색[Hartley Marsden]
총 93건 중 93건 출력
, 10/10 페이지
-
91
- CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer
- Mehanna, Hisham; Gaunt, Piers; Kong, Anthony; Hartley, Andrew; Sanghera, Paul; Forster, Martin; Sen, Mehmet; Paleri, Vinidh; Fong, Charles; Geropantas, Dinos; Srinivasan, Devraj; Garikipati, Satya; Moleron, Rafael; Casswell, Georgina; Aynsley, Eleanor; Ward, Amy; O’Toole, Lorcan; Mirza, Arafat; Firth, Charlotte; Humphreys, Isla; Fulton-Lieuw, Tessa; Roques, Tom; Nankivell, Paul; Institute of Head and Neck Studies and Education (InHANSE), Institute of Cancer and Genomic Sciences, University of Birmingham, B15 2TT, Birmingham, UK; Cancer Research UK Clinical Trials Unit, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, UK; King’s College London, London, UK; Queen Elizabeth Hospital, Birmingham, UK; Queen Elizabeth Hospital, Birmingham, UK; UCL Cancer Institute, UCLH, London, UK; St James’s University Hospital, Leeds, UK; The Royal Marsden, London, UK; Queen Elizabeth Hospital, Birmingham, UK; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK; Western General Hospital, Edinburgh, UK; Weston Park Hospital, Sheffield, UK; Aberdeen Royal Infirmary, Aberdeen, UK; University Hospitals Bristol NHS Foundation Trust, Bristol, UK; The James Cook University Hospital, Middlesbrough, UK; Queen’s Hospital Romford, London, UK; Castle Hill Hospital, Yorkshire, UK; Royal Preston Hospital, Preston, UK; ; (Trials, v.25, 2024, pp.50)
-
92
- PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer
- Mehanna, Hisham; McConkey, Chris C; Rahman, Joy K; Wong, Wai-Lup; Smith, Alison F; Nutting, Chris; Hartley, Andrew GJ; Hall, Peter; Hulme, Claire; Patel, Dharmesh K; Zeidler, Sandra Ventorin von; Robinson, Max; Sanghera, Bal; Fresco, Lydia; Dunn, Janet A; Institute of Head & Neck Studies and Education, University of Birmingham, Birmingham, UK; Warwick Clinical Trials Unit, University of Warwick, Coventry, UK; Warwick Clinical Trials Unit, University of Warwick, Coventry, UK; Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, UK; Academic Unit of Health Economics, University of Leeds, Leeds, UK; Royal Marsden Hospital, London, UK; University Hospital Birmingham, Birmingham, UK; Academic Unit of Health Economics, University of Leeds, Leeds, UK; Academic Unit of Health Economics, University of Leeds, Leeds, UK; Warwick Clinical Trials Unit, University of Warwick, Coventry, UK; Department of Pathology, Federal University of Espí rito Santo, Vitó ria, Brazil; Centre for Oral Health Research, Newcastle University, Newcastle upon Tyne, UK; Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, UK; University Hospitals Coventry and Warwickshire, Coventry, UK; Warwick Clinical Trials Unit, Univ; (Health technology assessment : HTA, v.21, 2017, pp.1-122)
-
93
- Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study
- Mehanna, Hisham; Rapozo, Davy; von Zeidler, Sandra V.; Harrington, Kevin J.; Winter, Stuart C.; Hartley, Andrew; Nankivell, Paul; Schache, Andrew G.; Sloan, Philip; Odell, Edward W.; Thavaraj, Selvam; Hunter, Keith D.; Shah, Ketan A.; Thomas, Gareth J.; Long, Anna; Amel-Kashipaz, Rasoul; Brown, Rachel M.; Conn, Brendan; Hall, Gillian L.; Matthews, Paul; Weir, Justin; Yeo, Yen; Pring, Miranda; West, Catharine M.L.; McCaul, James; Golusinski, Pawel; Sitch, Alice; Spruce, Rachel; Batis, Nikolaos; Bryant, Jennifer L.; Brooks, Jill M.; Jones, Terence M.; Buffa, Francesca; Haider, Syed; Robinson, Max; Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, United Kingdom.; National Cancer Institute of Brazil, Rio de Janeiro, Brazil.; Pathology Department and Biotechnology Post-graduation Program, Federal University of Espí rito Santo, Vitó ria, Brazil.; The Royal Marsden/The Institute of Cancer Research National Institute of Health Research Biomedical Research Centre, London, United Kingdom.; Department of ENT-Head and Neck Surgery, Churchill Hospital, Nuffield Department of Surgery, University of Oxford, Oxford, United Kingdom.; Hall-Edwards Radiotherapy Research Group, University Hospitals Birmingham, Birmingham, United Kingdom.; Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, United Kingdom.; Northwest Cancer Research Centre, Department of Molecular & Clinical Cancer Medicine, University of Liverpool Head & Neck Unit, University Hospital Aintree, Liverpool, United Kingdom.; Center for Oral; (Clinical Cancer research : an official journal of the American Association for Cancer Research, v.30, 2024, pp.356-367)
QUICK MENU
